These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 33338931)

  • 1. Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy.
    Isser A; Livingston NK; Schneck JP
    Biomaterials; 2021 Jan; 268():120584. PubMed ID: 33338931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomaterials as Local Niches for Immunomodulation.
    Adu-Berchie K; Mooney DJ
    Acc Chem Res; 2020 Sep; 53(9):1749-1760. PubMed ID: 32786230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Biomaterials for Cell-Specific Modulation and Restore of Cancer Immunotherapy.
    Ruan S; Huang Y; He M; Gao H
    Adv Sci (Weinh); 2022 May; 9(16):e2200027. PubMed ID: 35343112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
    Froimchuk E; Carey ST; Edwards C; Jewell CM
    Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
    Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Platforms for T Cell Modulation.
    Hickey JW; Kosmides AK; Schneck JP
    Int Rev Cell Mol Biol; 2018; 341():277-362. PubMed ID: 30262034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical Immunoengineering of T cells for Therapeutic Applications.
    Lei K; Kurum A; Tang L
    Acc Chem Res; 2020 Dec; 53(12):2777-2790. PubMed ID: 33258577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
    Rhodes KR; Green JJ
    Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells.
    Schluck M; Hammink R; Figdor CG; Verdoes M; Weiden J
    Front Immunol; 2019; 10():931. PubMed ID: 31130945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile Transformation of Murine and Human Primary Dendritic Cells into Robust and Modular Artificial Antigen-Presenting Systems by Intracellular Hydrogelation.
    Lin JC; Hsu CY; Chen JY; Fang ZS; Chen HW; Yao BY; Shiau GHM; Tsai JS; Gu M; Jung M; Lee TY; Hu CJ
    Adv Mater; 2021 Jul; 33(30):e2101190. PubMed ID: 34096117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles for generating antigen-specific T cells for immunotherapy.
    Est-Witte SE; Livingston NK; Omotoso MO; Green JJ; Schneck JP
    Semin Immunol; 2021 Aug; 56():101541. PubMed ID: 34922816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
    Xie YQ; Wei L; Tang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.
    Hammerich L; Binder A; Brody JD
    Mol Oncol; 2015 Dec; 9(10):1966-81. PubMed ID: 26632446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomaterial Strategies for Immunomodulation.
    Hotaling NA; Tang L; Irvine DJ; Babensee JE
    Annu Rev Biomed Eng; 2015; 17():317-49. PubMed ID: 26421896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
    Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
    Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.
    Shah SA; Oakes RS; Jewell CM
    Adv Drug Deliv Rev; 2024 Jun; 209():115315. PubMed ID: 38670230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomaterials promote
    Qin YT; Li YP; He XW; Wang X; Li WY; Zhang YK
    Front Immunol; 2023; 14():1165576. PubMed ID: 37153571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-Presenting Hybrid Colloidal Crystal Clusters for Promoting T cells Expansion.
    Shou X; Zhang H; Wu D; Zhong L; Ni D; Kong T; Zhao Y; Zhao Y
    Small; 2021 Apr; 17(14):e2006955. PubMed ID: 33711196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.